ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

New Atlas Showing nonwhite Mortality Rates Available

January 7, 1977

NCI Programs: Pediatric Brain Tumor Grants Awarded

April 16, 1999

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

HAS Authority Over Cancer Program Become Hot Issues; Fredrickson Opposes Exemption For NCI

October 29, 1976

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

February 28, 2003

NCI-Approved Clinical Trials

February 23, 2007